DR ANTHONY MELVIN CRASTO,WorldDrugTracker, helping millions, A 90 % paralysed man in action for you, I am suffering from transverse mylitis and bound to a wheel chair,With death on the horizon, This will not stop me, Gods call only..........
DR ANTHONY MELVIN CRASTO Ph.D ( ICT, Mumbai) , INDIA 29Yrs Exp. in the feld of Organic Chemistry,Working for GLENMARK PHARMA at Navi Mumbai, INDIA. Serving chemists around the world. Helping them with websites on Chemistry.Million hits on google, world acclamation from industry, academia, drug authorities for websites, blogs and educational contributio
n

Thursday 17 March 2016

Dr. Vandana Arora Sethi

Dr. Vandana Arora Sethi

Dr. Vandana Arora Sethi

Head of the Department at School of Pharmacy, Lloyd Institute of Management & Technology

links
  • Experience





    Reader

    Lloyd Institute of Management & Technology
     – Present (9 years 8 months)




    Lecturer

    Allana College of Pharmacy
     –  (1 year)




    Research Analyst

    Smart Analyst
     –  (5 months)

    Education



    Delhi University

    M.Pharm., Pharmaceutics, First- Gold medalist

    Activities and Societies: Debates and Anchoring
    (Open)1 honor or award
  • Honors & Awards

    LG Trophy for the Best Outgoing student

    Delhi Government

    Sai Medha Award for the best student

    Best Teacher Award

  • Cite this article as:
    Vandana Arora Sethi, Abdul W. Siddiqui, Govind Mohan, Development and Evaluation of Niosomal Formulation of Famciclovir, Asian Journal of Pharmaceutical Technology & Innovation, 03 (13); 2015. www.asianpharmtech.com
  • Development and Evaluation of Niosomal Formulation of Famciclovir

    Vandana Arora Sethi*1, Abdul W. Siddiqui2, Govind Mohan3
    1,3     Department of Pharmacy, NIMS University, Jaipur Rajasthan
    2        Department of Pharmacy, Mangalayatan University, Aligarh U.P.
    ________________________________________________________________________________________________________________
    ABSTRACT
    Niosomes are one of the best and most effective among these carriers system.               Because of the presence of hydrophilic, lipophilic and amphiphilic moieties in the structure, these niosomes can accommodate various drug molecules with a wide range of solubility. So, these may act as a depot, releasing the drug in a defined manner. Rationale behind the present study is to improve the oral bioavailability of Famciclovir by preparing niosomes. Encapsulation of Famciclovir in lipophilic vesicular structure may be expected to enhance the dissolution, oral absorption and prolong the existence of the drug in the systemic circulation. The niosomal dispersions were formulated using various combinations of cholesterol and spans. The formulations were evaluated in-vitro and in-vivo and compared with the marketed preparation of Famciclovir.
    Key-words: liposomes, niosomal dispersion, famciclovir, in vivo study.
    ______________________________________________________________________________________________________________________________________________________
    Corresponding Author: Vandana Arora Sethi, Department of Pharmacy, NIMS University, Jaipur, Rajasthan, India. Mob.no. +919873250790






  • ///////////